Summit Lends TB Program To Lilly Philanthropy
This article was originally published in The Pink Sheet Daily
Executive Summary
UK biotech keeps rights to sell new drugs in wealthier countries.
You may also be interested in...
FDA Priority Review Voucher Guidance Coming: Incentive Has Low Visibility
FDA is planning a public meeting to discuss the new priority review voucher system to begin implementing the new program
FDA Priority Review Voucher Guidance Coming: Incentive Has Low Visibility
FDA is planning a public meeting to discuss the new priority review voucher system to begin implementing the new program
India’s Advinus Signs On With Genzyme In Malaria Research
Development of malaria drugs could qualify Genzyme for a priority review voucher under FDA’s tropical disease incentive.